As of April 16, 2025, Maravai LifeSciences (MRVI) has a market cap of $0.44 billion USD. According to our data, Maravai LifeSciences is ranked No.6103 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.44 B |
-43.08%
|
Dec 31, 2024 | $0.77 B |
-16.79%
|
Dec 29, 2023 | $0.93 B |
-54.23%
|
Dec 30, 2022 | $2.03 B |
-65.85%
|
Dec 31, 2021 | $5.94 B |
49.38%
|
Dec 31, 2020 | $3.98 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Danaher
DHR
|
$135.88 B |
0.003 M
|
![]() USA
|
![]() Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
![]() USA
|
![]() Agilent Technologies
A
|
$29.40 B |
-0.001 M
|
![]() USA
|
![]() Illumina
ILMN
|
$11.80 B |
-0.000 M
|
![]() USA
|
![]() Qiagen
QGEN
|
$8.98 B |
0.000 M
|
![]() Netherlands
|
![]() Charles River Laboratories
CRL
|
$5.20 B |
-0.000 M
|
![]() USA
|
![]() Bruker
BRKR
|
$5.82 B |
0.000 M
|
![]() USA
|
![]() Waters Corporation
WAT
|
$19.24 B |
-0.000 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Avantor
AVTR
|
$10.49 B |
-0.000 M
|
![]() USA
|
![]() Repligen
RGEN
|
$7.11 B |
-0.000 M
|
![]() USA
|
Market Cap | = | MRVI Stock Price | * | MRVI Shares Outstanding |
= | $1.73 | * | 0.14 B | |
= | $0.44 B |